Nvest Financial LLC Sells 112 Shares of Danaher Co. (NYSE:DHR)

Nvest Financial LLC lessened its stake in Danaher Co. (NYSE:DHR) by 3.5% in the fourth quarter, HoldingsChannel reports. The firm owned 3,093 shares of the conglomerate’s stock after selling 112 shares during the period. Nvest Financial LLC’s holdings in Danaher were worth $710,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Foster Victor Wealth Advisors LLC grew its position in shares of Danaher by 45.4% during the 4th quarter. Foster Victor Wealth Advisors LLC now owns 53,029 shares of the conglomerate’s stock worth $12,640,000 after buying an additional 16,555 shares during the period. R Squared Ltd bought a new position in Danaher during the 4th quarter worth approximately $83,000. Mayflower Financial Advisors LLC grew its holdings in Danaher by 3.1% during the fourth quarter. Mayflower Financial Advisors LLC now owns 2,534 shares of the conglomerate’s stock valued at $582,000 after purchasing an additional 77 shares during the period. BSW Wealth Partners increased its stake in Danaher by 3.7% in the fourth quarter. BSW Wealth Partners now owns 3,713 shares of the conglomerate’s stock valued at $852,000 after purchasing an additional 134 shares in the last quarter. Finally, Stonegate Investment Group LLC raised its holdings in Danaher by 2.2% in the fourth quarter. Stonegate Investment Group LLC now owns 225,199 shares of the conglomerate’s stock worth $51,694,000 after purchasing an additional 4,830 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on DHR. UBS Group lowered their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Evercore ISI increased their price target on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. TD Cowen raised their price target on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Scotiabank initiated coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Finally, Citigroup dropped their target price on shares of Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Six research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average target price of $285.81.

Danaher Stock Performance

DHR opened at $247.77 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The business’s 50-day simple moving average is $236.09 and its 200 day simple moving average is $253.66. The firm has a market capitalization of $178.96 billion, a PE ratio of 47.29, a PEG ratio of 4.43 and a beta of 0.83. Danaher Co. has a 52-week low of $225.42 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. During the same quarter in the previous year, the company posted $2.09 EPS. As a group, sell-side analysts expect that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.